NCT01427179 Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)
| NCT ID | NCT01427179 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Spontaneous Coronary Artery Dissection |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2011-05 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2011-05 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the research is to identify mutations (defects in the genetic blueprint) that cause spontaneous coronary artery dissection (SCAD), in other words, spontaneous tears in blood vessels that supply the heart. Some mutations may be inherited (passed on) from a parent without an apparent blood vessel problem while others may develop for the first time in the affected person.
Eligibility Criteria
Inclusion Criteria: * Men and women able to give informed consent and complete a 2 page questionnaire * Diagnosis of one or more episodes of spontaneous coronary artery dissection (SCAD) * Biological parent of individual with SCAD * Relative with fibromuscular dysplasia, arterial aneurysm, or arterial dissection Exclusion Criteria: * Lack of confirmation of SCAD diagnosis
Contact & Investigator
Sharonne N. Hayes, M.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT01427179 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spontaneous Coronary Artery Dissection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01427179 currently recruiting?
Yes, NCT01427179 is actively recruiting participants. Contact the research team at MayoSCAD@Mayo.edu for enrollment information.
Where is the NCT01427179 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT01427179 clinical trial?
NCT01427179 is sponsored by Mayo Clinic. The principal investigator is Sharonne N. Hayes, M.D. at Mayo Clinic. The trial plans to enroll 2,000 participants.